- €432.12m
- €419.04m
- €236.52m
Equasens drops after Q2 results
Brief: Equasens Maintains 2024 Forecast
Brief: Equasens Posts H1 Revenue Of EUR 108 Mln
Stifel ups Equasens to 'buy' on expected rebound, shares rise
Brief: Equasens Q1 Revenue At 53.3 Million
Brief: Equasens Posts FY Revenue Up At EUR 219.7 MLN
Brief: EQUASENS FY Net Income EUR 48.9 Million
Europe Research Roundup: Morphosys, Renishaw, Verallia
French and Benelux stocks-Factors to watch
Brief: Equasens Acquires Majority Stake In Digipharmacie
Equasens tracks worst day in two decades as growth halts in Q3
French and Benelux stocks-Factors to watch
Brief: Equasens Says Growth Momentum Of Pharmagest Division Remains Solid
French and Benelux stocks-Factors to watch
Brief: Equasens H1 Net Profit Attributable To Group Shareholders Rises To 22.0 Mln Euros
Brief: Euronext Announces Results Of Annual Review For CAC Family Indices
Brief: Equasens H1 Revenue Up 9% To EUR 112.62 Mln
Brief: Equasens Q1 Revenue Rises To EUR 56.3 Million
Brief: Equasens Acquires Pratilog, Speech2sense